BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25506890)

  • 1. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
    Yang P; Huo Z; Liao H; Zhou Q
    Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
    Gordeeva O
    Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.
    Shang B; Gao A; Pan Y; Zhang G; Tu J; Zhou Y; Yang P; Cao Z; Wei Q; Ding Y; Zhang J; Zhao Y; Zhou Q
    Cell Death Dis; 2014 Jun; 5(6):e1285. PubMed ID: 24901056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
    Bodey B
    Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
    Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
    J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
    Nin DS; Deng LW
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cancer/testis antigens (CTAs) in breast cancer.
    Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
    Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
    Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
    Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential immune-eliciting cancer testis antigens in colorectal cancer.
    Chi Soh JE; Abu N; Jamal R
    Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause and consequence of cancer/testis antigen activation in cancer.
    Whitehurst AW
    Annu Rev Pharmacol Toxicol; 2014; 54():251-72. PubMed ID: 24160706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
    Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
    Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
    Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis antigens and urological malignancies.
    Kulkarni P; Shiraishi T; Rajagopalan K; Kim R; Mooney SM; Getzenberg RH
    Nat Rev Urol; 2012 Jun; 9(7):386-96. PubMed ID: 22710665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.
    Maine EA; Westcott JM; Prechtl AM; Dang TT; Whitehurst AW; Pearson GW
    Oncotarget; 2016 Mar; 7(12):14708-26. PubMed ID: 26895102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
    Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
    Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
    Sharma P; Shen Y; Wen S; Bajorin DF; Reuter VE; Old LJ; Jungbluth AA
    Clin Cancer Res; 2006 Sep; 12(18):5442-7. PubMed ID: 17000678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.